Back to Conditions

Dapagliflozin: Beyond Diabetes

Dapagliflozin: Beyond Diabetes
Prescription Medicines Editorial 28 October 2025

Dapagliflozin blocks SGLT2, the transporter in the kidney that reabsorbs glucose back into the blood. Glucose is passed out in the urine instead, and blood sugar falls. That was the original purpose. What has changed the drug's place in medicine is that trials found substantial benefits in heart failure and kidney disease regardless of whether the person has diabetes at all - so a growing number of people take it with entirely normal blood sugar.

Follow the instructions on your label. This guide contains no doses.

Why someone without diabetes takes it

Heart failure - trials in heart failure with reduced ejection fraction, and subsequently with preserved ejection fraction, found reduced hospitalisation and cardiovascular death, in people with and without diabetes. SGLT2 inhibitors are now core heart failure treatment alongside an ACE inhibitor or ARB, a beta blocker and a mineralocorticoid antagonist.

Chronic kidney disease - trials found slowed progression of kidney disease and reduced kidney failure, again independent of diabetes.

The mechanisms are not fully settled and appear to involve changes in kidney pressure regulation, sodium handling and cardiac energy use rather than glucose.

See heart failure medicines, spironolactone and empagliflozin, which does much the same job.

The sick day rule still applies

This is the point that gets missed when someone without diabetes is prescribed it - they do not think of it as a diabetes medicine and have not been given diabetes sick day rules.

Stop dapagliflozin during acute illness - vomiting, diarrhoea, fever, dehydration or reduced food intake - and restart when eating and drinking normally. It is also stopped before surgery and before procedures requiring fasting.

The reason is ketoacidosis, and the form SGLT2 inhibitors cause is unusual.

Euglycaemic ketoacidosis

Normally diabetic ketoacidosis comes with very high blood glucose, which is what alerts people. With an SGLT2 inhibitor, glucose is being excreted in the urine, so blood sugar can be normal or only mildly raised while ketoacidosis develops.

That removes the usual warning, and it is why cases are missed - in emergency departments as well as at home. Someone without diabetes is even less likely to have it considered.

Seek urgent medical help for nausea and vomiting, abdominal pain, rapid or deep breathing, unusual tiredness, confusion, or a sweet smell on the breath - even if your blood glucose is normal, and even if you do not have diabetes.

Say that you take an SGLT2 inhibitor, because it changes what should be tested. Ketones are the relevant test, not glucose.

The eGFR dip

Kidney function is checked before starting and periodically afterwards.

Expect a small early fall in eGFR that then stabilises. It reflects a change in pressure within the kidney rather than damage, and it is part of how the drug protects the kidney over time.

It is not a reason to stop, and stopping because of it forfeits the benefit. A continuing fall is different and needs review.

See medicines that affect your kidneys.

Genital infections

Passing glucose in the urine makes genital thrush considerably more likely, in both men and women, commonest in the first months.

Good hygiene and thorough drying help. It is easily treated and not a reason to stop - see fluconazole.

Seek urgent medical help for severe pain, tenderness, redness or swelling of the genitals or the area between the genitals and anus, particularly with fever. Fournier's gangrene is a rare but rapidly destructive infection of that area and needs emergency treatment.

Blood pressure and diuretics

Dapagliflozin has a mild diuretic effect, so blood pressure can fall and dizziness on standing is common early.

That matters more in older people and in anyone already on a diuretic - a furosemide dose is sometimes reduced when an SGLT2 inhibitor is started.

See furosemide and medicines in hot weather.

What it does not do

It does not cause hypoglycaemia on its own. Combined with insulin or a sulfonylurea it can, and those doses are often reduced - see glimepiride.

It causes modest weight loss rather than gain.

Its glucose-lowering effect diminishes as kidney function declines - but the heart and kidney benefits persist well below that point, which is why it may be continued even when it is no longer doing anything for blood sugar.

In type 1 diabetes

SGLT2 inhibitors are not routinely used in type 1 diabetes because the ketoacidosis risk is considerably higher. Where used, it is under specialist supervision with clear ketone monitoring.

Taking it

Once daily, with or without food, usually in the morning since urine output increases.

Expect to pass more urine, particularly early. Drink adequately - and note that dehydration is exactly what the sick day rule guards against.

Related reading: Tirzepatide: Two Hormones at Once, with more on what medicines are prescribed for in Conditions.